Edition:
United Kingdom

Marksans Pharma Ltd (MARK.NS)

MARK.NS on National Stock Exchange of India

27.95INR
8:51am GMT
Change (% chg)

Rs0.15 (+0.54%)
Prev Close
Rs27.80
Open
Rs27.95
Day's High
Rs28.40
Day's Low
Rs27.80
Volume
552,405
Avg. Vol
1,771,110
52-wk High
Rs47.70
52-wk Low
Rs23.55

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Sep 2,690.41 0.479
Jun 2,352.53 0.583
FY 2018 Mar '18 1,993.94 -0.168
Dec 2,184.34 0.410
Sep 2,738.09 0.230
Jun 2,210.56 0.333
FY 2017 Mar '17 1,847.49 -0.152
Dec 2,152.39 0.243
Sep 1,804.26 0.017
Jun 1,867.47 0.110
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 88.58 31.12 34.38
P/E High - Last 5 Yrs. 202.74 40.55 46.19
P/E Low - Last 5 Yrs. 3.32 23.99 24.58
Beta 1.92 0.91 0.91
Price to Sales (TTM) 2.45 4.00 6.26
Price to Book (MRQ) -- 5.02 5.20
Price to Tangible Book (MRQ) -- 5.76 6.73
Price to Cash Flow (TTM) 34.23 23.21 24.17
% Owned Institutions -- 0.94 1.75

Dividends

  Company industry sector
Dividend Yield 0.10 1.55 1.44
Dividend Yield - 5 Year Avg 0.21 1.56 1.46
Dividend 5 Year Growth Rate -- 4.22 4.93
Payout Ratio(TTM) 12.73 45.69 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 18.37 2.31 8.17
Sales (TTM) vs TTM 1 Yr. Ago -7.87 4.77 6.48
Sales - 5 Yr. Growth Rate 16.63 10.00 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago 202.90 17.44 23.23
EPS (TTM) vs TTM 1 Yr. Ago -57.13 -- --
EPS - 5 Yr. Growth Rate -- 9.90 10.50
Capital Spending - 5 Yr. Growth Rate 39.36 15.23 14.62

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.20 2.30
Current Ratio (MRQ) -- 3.02 3.12
LT Debt to Equity (MRQ) -- 8.85 11.47
Total Debt to Equity (MRQ) -- 12.66 16.03
Interest Coverage (TTM) 8.43 35.18 30.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 40.70 54.40 54.45
Gross Margin - 5 Yr. Avg. 38.62 51.85 52.36
EBITD Margin (TTM) 8.13 -- --
EBITD - 5 Yr. Avg 14.77 18.40 13.10
Operating Margin (TTM) 4.05 14.43 6.05
Operating Margin - 5 Yr. Avg. 11.77 14.54 8.39
Pre-Tax Margin (TTM) 4.12 14.96 7.01
Pre-Tax Margin - 5 Yr. Avg. 11.58 14.97 8.67
Net Profit Margin (TTM) 3.06 11.16 3.11
Net Profit Margin - 5 Yr. Avg. 9.34 11.22 4.86
Effective Tax Rate (TTM) 25.61 23.47 23.27
Effective Tax Rate - 5 Yr. Avg. 19.36 23.66 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 11,178,110 997,645,050 873,304,761
Net Income/Employee (TTM) 342,558 118,307,527 103,509,273
Receivable Turnover (TTM) -- 5.82 5.80
Inventory Turnover (TTM) -- 2.68 3.57
Asset Turnover (TTM) -- 0.99 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.99 11.45
Return on Assets - 5 Yr. Avg. 11.52 13.28 12.50
Return on Investment (TTM) -- 15.55 14.96
Return on Investment - 5 Yr. Avg. 26.35 17.29 16.23
Return on Equity (TTM) -- 16.93 16.53
Return on Equity - 5 Yr. Avg. 27.24 18.21 17.36
  1 Year 3 Year 5 Year
Sales % -14.12 6.79 16.63
EPS (TTM) % -87.88 -50.08 --
Dividend % -58.33 -20.63 --
Note: Units in Millions of US Dollars

Performance for Marksans Pharma Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 21.88 21.40 99 20
13 Week 11.66 10.06 99 34
26 Week -8.15 -14.23 99 28
52 Week -14.00 -24.03 99 12
YTD 20.20 0.60 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.42%
# of Holders: 9
Total Shares Held: 14,000,694
3 Mo. Net Change: 222,496
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 3
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.